IRFEN Junior susp 100 mg/5ml fl 200 ml

7680669330019 CH-66933 M01AE01 07.10.1.

Active substances:

IRFEN Junior susp 100 mg/5ml fl 200 ml
IRFEN Junior susp 100 mg/5ml fl 200 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6693301
CPT
-
Packaging group
200
Unit
ml
Composition
ibuprofenum 100 mg, acidum citricum, xanthani gummi, hypromellosum, glycerolum, natrii chloridum, polysorbatum 80, aromatica (Orange) cum alcohol benzylicus q.s., vanillinum, natrii cyclamas, maltitolum liquidum 2 g, acesulfamum kalicum, sucralosum, natrii benzoas 10 mg, aqua, ad suspensionem pro 5 ml corresp. natrium 7.375 mg.

Articles (1)

Irfen Junior, Suspension
suspension
200
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/07/2025
Patient information leaflet
Français
11/07/2025
Patient information leaflet
Italien
11/07/2025
Professional SmPC
Allemand
11/07/2025
Professional SmPC
Français
11/07/2025
Professional SmPC
Italien
11/07/2025

Detailed composition

Substance Quantity Type Category
ibuprofenum
100.0 MG Substance Wirkstoff (Principe actif)
acidum citricum
- Substance HNIDK
xanthani gummi
- Substance HNIDK
hypromellosum
- Substance HNIDK
glycerolum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aromatica
- Substance AROMA
alcohol benzylicus
- Substance HBESI
vanillinum
- Substance AIMDK
natrii cyclamas
- Substance AIMDK
maltitolum liquidum
2.0 G Substance HBESI
acesulfamum kalicum
- Substance HNIDK
sucralosum
- Substance HNIDK
natrii benzoas
10.0 MG Substance HBESI
aqua
- Substance HNIDK
natrium
7.375 MG Substance HBESI

Reimbursement information

Public price
CHF 13.55
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2019

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66933
Drug name
Irfen Junior, Suspension
Galenic form
SUOR
ATC Code
M01AE01
Authorization status
Z
Dispensation category
B
First authorization
07/12/2018
Authorization expiration date
31/12/9999
IT number
07.10.1.
Domain
Human medicine
Field of application
Antiphlogistikum, Analgetikum, Antipyretikum

Packaging details

Description (FR)
IRFEN Junior susp 100 mg/5ml fl 200 ml
Description (DE)
IRFEN Junior Susp 100 mg/5ml Fl 200 ml
Market launch
07/12/2018
Narcotic (BTM)
No

Original drug

Algifor Junior, Suspension
CHF 13.95
View original
Buy us a coffee Explore the data